TITLE

Clinical Trials, Disparities, and Financial Burden: It's Time to Intervene

AUTHOR(S)
Moy, Beverly
PUB. DATE
June 2015
SOURCE
Oncologist;Jun2015, Vol. 20 Issue 6, p571
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The additional financial burden of clinical trial participation and the lack of availability of trials at safety net facilities make it essentially impossible for underserved patients to participate. If allowed to continue, these trends will ensure that only affluent cancer patients will be able to participate in clinical trials. Interventions to better handle financial stresses and widespread policy change are necessary to optimize high‐quality care for all patients with cancer.
ACCESSION #
103196603

 

Related Articles

  • Recognizing the Financial Burden of Cancer Patients in Clinical Trials. Nipp, Ryan D.; Powell, Elizabeth; Chabner, Bruce; Moy, Beverly // Oncologist;Jun2015, Vol. 20 Issue 6, p572 

    Clinical trials often represent an increasingly important option for patients with cancer, thus oncologists participating in clinical research need to consider and address the financial burden associated with trial participation. Future research efforts should focus on developing formal...

  • Exploratory research into cancer patients' attitudes to clinical trials. Ramers-Verhoeven, Corina W.; Perrone, Francesco; Oliver, Kathy // Ecancermedicalscience;2014, Vol. 8 Issue 413-446, p1 

    A qualitative survey was carried out in six countries to gather insights into potential barriers to patient participation in cancer clinical trials (CTs) to help stakeholders develop strategies to improve recruitment and participation. While the research was exploratory in nature, the findings...

  • Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials. Bowering, Gale // Canadian Oncology Nursing Journal;Fall2012, Vol. 22 Issue 4, p287 

    The article reviews the book ``Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials,'' by T.M. Beer and L.W. Axmaker.

  • Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials. Bowering, Gale // Canadian Oncology Nursing Journal;Fall2012, Vol. 22 Issue 4, p288 

    No abstract available.

  • Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. Stoneham, Sara J.; Hale, Juliet P.; Rodriguez‐Galindo, Carlos; Dang, Ha; Olson, Thomas; Murray, Matthew; Amatruda, James F.; Thornton, Claire; Arul, G. Suren; Billmire, Deborah; Krailo, Mark; Stark, Dan; Covens, Al; Hurteau, Jean; Stenning, Sally; Nicholson, James C.; Gershenson, David; Frazier, A. Lindsay // Oncologist;Jul2014, Vol. 19 Issue 7, p689 

    Because the tumors of adolescence and young adulthood (AYA) are distinct from those that occur earlier and later in life, the most common tumors in this age group are termed “rare.” We offer a collaborative, cross‐disciplinary, evidence‐based approach, advocated and...

  • Clinical Trial Information As a Measure of Quality Cancer Care. Wei Chua; Clarke, Stephen J. // Journal of Oncology Practice;May2010, Vol. 6 Issue 3, p170 

    In this article the authors discuss on using clinical trial information as quality measure in medical oncology. It states that participation of patients in clinical trials enables them to access new treatment options and improved patient outcomes. Moreover, it mentions measures that allows...

  • Will my child do better if she enrolls in a clinical trial? Smith, Malcolm A.; Joffe, Steven // Cancer (0008543X);Oct2018, Vol. 124 Issue 20, p3965 

    The question of whether children with cancer who enroll in clinical trials have superior outcomes compared with those who do not participate has been pursued for more than 4 decades, and recent studies have provided conflicting answers. Whether clinical trial participation influences outcome has...

  • Publicly Funded Clinical Trials and the Future of Cancer Care. Schilsky, Richard L. // Oncologist;Feb2013, Vol. 18 Issue 2, p232 

    Publicly sponsored trials, conducted primarily by cooperative groups sponsored by the National Cancer Institute, and commercially sponsored trials are necessary to create new knowledge, improve the care of oncology patients, and develop new drugs and devices. Commercial sponsors launch clinical...

  • Abstract 1 -- Publicly Funded Clinical Trials and the Future of Cancer Care. Schilsky, Richard L. // Oncologist;Oct2012 Supplement, Vol. 17 Issue S2, p1 

    An abstract of the article "Publicly Funded Clinical Trials and the Future of Cancer Care," by Richard L. Schilsky is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics